Pregnancy and lactation
Session: Poster Session B
Melanie H. Jacobson, PhD, MPH (she/her/hers)
Associate Director
Johnson and Johnson Innovative Medicine, United States
Meritxell Sabidó, MD, PhD
Director RWE Neurology & Immunology
Merck Healthcare KGaA
Darmstadt, Germany
Ana Sofia Afonso
Eli Lilly & Company, Netherlands
Adebola Ajao, PhD (she/her/hers)
Epidemiologist
Center for Drug Evaluation and Research, Food and Drug Administration, United States
Eman A. Alghamdi, MPharm
Senior Drug Safety Expert
Drug Safety and Risk Management department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia., Saudi Arabia
Susan Andrade, ScD
Research Scientist
Harvard Pilgrim Health Care Institute
Boston, United States
Dimitri Bennett, MD, MPH, FISPE
Sr. Director Epidemiology
Takeda, United States
Vineetkumar Kharat
Quantitative Safety and Epidemiology, Novartis Pharmaceuticals Ltd., United States
Marie-Laure Kürzinger, MSc
Head of Pharmacoepidemiology – General Medicines
Sanofi
Paris - Gentilly, France
Maryline Le Noan-Lainé
Eli Lilly, Global Patient Safety, Cork Ireland
Cork, Ireland
Ditte Mølgaard-Nielsen, PhD
Novo Nordisk, Denmark
Gayle Murray, MSW
Epidemiology Specialist
Janssen R&D
Barre, United States
Elena Rivero-Ferrer, MD, MPH, FISPE (she/her/hers)
Senior Director, Epidemiology
RTI Health Solutions, Barcelona, Spain
BARCELONA, Spain
Sandra Lopez Leon, MD PhD
Director Pharmacoepidemiologist
Novartis Pharma
East Hanover, United States